BIOSCAN
ActiveSummary
BIOSCAN has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €540,737 and a net result of €41,514. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 72% of 10,757 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Directors
1 director, no change since 2023
JANSSENS Stefan Celestine Raymond Gustaaf
CurrentDirector (not named in the articles)
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
1 person since 2023, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| JANSSENS Stefan Celestine Raymond Gustaaf |
|
Owners and capital
Capital and shareholders
Capital over the years
- 23-08-2023 Converted to unavailable equity